Your browser doesn't support javascript.
loading
Transient central retina artery occlusion in patients undergoing intravitreal anti vegf injections.
Damasceno, Nadyr A; Yannuzzi, Nicolas A; Maia, Mauricio; Eid Farah, Michel; Flynn, Harry W; Damasceno, Eduardo F.
Afiliação
  • Damasceno NA; Department of Ophthalmology, 282806Marcilio Dias Navy Hospital, Rio de Janeiro, RJ, Brazil.
  • Yannuzzi NA; Department of Ophthalmology, Federal University of São Paulo, Paulista Medical School, SP, Brazil.
  • Maia M; Department of Ophthalmology, Bascom Palmer Eye Institute, 158424University of Miami Miller School of Medicine, Miami, FL, USA.
  • Eid Farah M; Department of Ophthalmology, Federal University of São Paulo, Paulista Medical School, SP, Brazil.
  • Flynn HW; Department of Ophthalmology, Federal University of São Paulo, Paulista Medical School, SP, Brazil.
  • Damasceno EF; Department of Ophthalmology, Bascom Palmer Eye Institute, 158424University of Miami Miller School of Medicine, Miami, FL, USA.
Eur J Ophthalmol ; 32(5): 2819-2823, 2022 Sep.
Article em En | MEDLINE | ID: mdl-34962172
PURPOSE: To evaluate the occurrence of transient central retinal artery occlusion following intravitreal anti-vascular endothelial growth factor injection. METHODS: Prospective, observational study of 807 patients (807 eyes) who were given intravitreal injections of ranibizumab or aflibercept to treat any cause of retinal vascular diseases between 1 January 2017 and 30 November 2018 at the Federal Fluminense University Hospital in Niteroi, and a private facility in Rio de Janeiro, Brazil. Patients who did not present transient central retinal artery occlusion were excluded. RESULTS: Among 4069 injections, only 18 patients (0.44%) presented transient central retinal artery occlusion, 14 mild cases (77.7%), and 4 severe cases (22.3%). The clinical factors associated with more severe cases of transient central retinal artery occlusion were the duration of the transient central retinal artery occlusion (p = 0.001), number of prior injections (p = 0.01), and a positive carotid Doppler test (p = 0.01). Twelve cases (66.6%) had positive carotid artery obstruction (atheroma plaque size ≥70%) while 6 cases (33.3%) had negative carotid artery obstruction (atheroma plaque size <70%). The age group >60 years old (p = 0.06), cup/disc ratio >0.6 (p = 0.06), and pseudophakic lens status were also factors with association with transient central retinal artery occlusion, although did not meet criteria for statistical significance. The only patient who experienced a recurrent episode of transient central retinal artery occlusion had diabetic macular edema, positive carotid Doppler test, and cup/optic disc ratio >0.6. CONCLUSION: Transient central retinal artery occlusion is a rare adverse event that can appear in patients with retinal vascular disease receiving anti-vascular endothelial growth factor therapy. The atheroma plaque size and the number of prior injections can be associated with the severity of the event.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oclusão da Veia Retiniana / Oclusão da Artéria Retiniana / Edema Macular / Retinopatia Diabética / Placa Aterosclerótica Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Humans / Middle aged País/Região como assunto: America do sul / Brasil Idioma: En Revista: Eur J Ophthalmol Assunto da revista: OFTALMOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oclusão da Veia Retiniana / Oclusão da Artéria Retiniana / Edema Macular / Retinopatia Diabética / Placa Aterosclerótica Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Humans / Middle aged País/Região como assunto: America do sul / Brasil Idioma: En Revista: Eur J Ophthalmol Assunto da revista: OFTALMOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil País de publicação: Estados Unidos